Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: LIVER NEOPLASMS - MORTALITY , . Treffer: 38

2019

Korda, D; Doros, A; Piros, L; Gerlei, Z; Haboub-Sandil, A; Mándli, T; Fazakas, J; Deák, ÁP; Máthé, Z Liver Transplant for Metastatic Neuroendocrine Tumors: A Single-Center Experience in Hungary.
Transplant Proc. 2019; 51(4):1251-1253 Doi: 10.1016/j.transproceed.2019.04.010
Web of Science PubMed FullText FullText_MUG

 

2018

Margonis, GA; Buettner, S; Andreatos, N; Wagner, D; Sasaki, K; Galjart, B; Kamphues, C; Pawlik, TM; Poultsides, G; Kaczirek, K; Lønning, PE; Verhoef, C; Kreis, ME; Wolfgang, CL; Weiss, MJ The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
J Surg Oncol. 2018; 118(7):1074-1080 Doi: 10.1002/jso.25251
Web of Science PubMed FullText FullText_MUG

 

Qu, Z; Ling, Q; Gwiasda, J; Xu, X; Schrem, H; Beneke, J; Kaltenborn, A; Krauth, C; Mix, H; Klempnauer, J; Emmanouilidis, N Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany.
Langenbecks Arch Surg. 2018; 403(5): 643-654. Doi: 10.1007/s00423-018-1696-8
Web of Science PubMed FullText FullText_MUG

 

2017

Aigelsreiter, A; Neumann, J; Pichler, M; Halasz, J; Zatloukal, K; Berghold, A; Douschan, P; Rainer, F; Stauber, R; Haybaeck, J; Denk, H; Lackner, C Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis.
Liver Int. 2017; 37(4):600-610 Doi: 10.1111/liv.13325
Web of Science PubMed FullText FullText_MUG

 

Gwiasda, J; Schrem, H; Kaltenborn, A; Mahlmann, J; Mix, H; Lehner, F; Kayser, N; Klempnauer, J; Kulik, U Introduction of the resection severity index as independent risk factor limiting survival after resection of colorectal liver metastases.
Surg Oncol. 2017; 26(4): 382-388. Doi: 10.1016/j.suronc.2017.08.002
Web of Science PubMed FullText FullText_MUG

 

Gwiasda, J; Schulte, A; Kaltenborn, A; Ramackers, W; Kleine, M; Beetz, O; Klempnauer, J; Emmanouilidis, N; Schrem, H Identification of the resection severity index as a significant independent prognostic factor for early mortality and observed survival >5 and >10 years after liver resection for hepatocellular carcinoma.
Surg Oncol. 2017; 26(2): 178-187. Doi: 10.1016/j.suronc.2017.03.004
Web of Science PubMed FullText FullText_MUG

 

2016

Buettner, S; Gani, F; Amini, N; Spolverato, G; Kim, Y; Kilic, A; Wagner, D; Pawlik, TM The relative effect of hospital and surgeon volume on failure to rescue among patients undergoing liver resection for cancer.
Surgery. 2016; 159(4):1004-1012 Doi: 10.1016/j.surg.2015.10.025
Web of Science PubMed FullText FullText_MUG

 

Kulik, U; Schrem, H; Bektas, H; Klempnauer, J; Lehner, F Prognostic relevance of hematological profile before resection for colorectal liver metastases.
J Surg Res. 2016; 206(2): 498-506. Doi: 10.1016/j.jss.2016.08.012
Web of Science PubMed FullText FullText_MUG

 

2015

Hoffmann, K; Ganten, T; Gotthardtp, D; Radeleff, B; Settmacher, U; Kollmar, O; Nadalin, S; Karapanagiotou-Schenkel, I; von Kalle, C; Jäger, D; Büchler, MW; Schemmer, P Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial.
BMC Cancer. 2015; 15(11):392-392 Doi: 10.1186/s12885-015-1373-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kaczirek, K; Ciuleanu, TE; Vrbanec, D; Marton, E; Messinger, D; Liegl-Atzwanger, B; Wrba, F; Knittelfelder, R; Lindner, E; Zielinski, CC; Streubel, B; Brodowicz, T FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study.
Clin Colorectal Cancer. 2015; 14(2):91-98 Doi: 10.1016/j.clcc.2014.12.003
Web of Science PubMed FullText FullText_MUG

 

2014

Flecken, T; Schmidt, N; Hild, S; Gostick, E; Drognitz, O; Zeiser, R; Schemmer, P; Bruns, H; Eiermann, T; Price, DA; Blum, HE; Neumann-Haefelin, C; Thimme, R Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma.
Hepatology. 2014; 59(4):1415-1426 Doi: 10.1002/hep.26731 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Friedrich, K; Wannhoff, A; Kattner, S; Brune, M; Hov, JR; Weiss, KH; Antoni, C; Dollinger, M; Neumann-Haefelin, C; Seufferlein, T; Schemmer, P; Schirmacher, P; Stremmel, W; Gotthardt, DN PNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival.
J Gastroenterol Hepatol. 2014; 29(7):1477-1484 Doi: 10.1111/jgh.12540
Web of Science PubMed FullText FullText_MUG

 

Hucke, F; Pinter, M; Graziadei, I; Bota, S; Vogel, W; Müller, C; Heinzl, H; Waneck, F; Trauner, M; Peck-Radosavljevic, M; Sieghart, W How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma.
J Hepatol. 2014; 61(6):1287-1296 Doi: 10.1016/j.jhep.2014.07.002
Web of Science PubMed FullText FullText_MUG

 

Hucke, F; Sieghart, W; Pinter, M; Graziadei, I; Vogel, W; Müller, C; Heinzl, H; Waneck, F; Trauner, M; Peck-Radosavljevic, M The ART-strategy: sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE.
J Hepatol. 2014; 60(1):118-126 Doi: 10.1016/j.jhep.2013.08.022
Web of Science PubMed FullText FullText_MUG

 

Niederkorn, A; Wackernagel, W; Artl, M; Schwantzer, G; Aigner, B; Richtig, E Response of patients with metastatic uveal melanoma to combined treatment with fotemustine and sorafenib.
Acta Ophthalmol. 2014; 92(8):e696-e697 Doi: 10.1111/aos.12432 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Stampfl, U; Bermejo, JL; Sommer, CM; Hoffmann, K; Weiss, KH; Schirmacher, P; Schemmer, P; Kauczor, HU; Richter, GM; Radeleff, BA; Longerich, T Efficacy and nontarget effects of transarterial chemoembolization in bridging of hepatocellular carcinoma patients to liver transplantation: a histopathologic study.
J Vasc Interv Radiol. 2014; 25(7):1018-1026 Doi: 10.1016/j.jvir.2014.03.007
Web of Science PubMed FullText FullText_MUG

 

2013

Aigelsreiter, A; Ress, AL; Bettermann, K; Schauer, S; Koller, K; Eisner, F; Kiesslich, T; Stojakovic, T; Samonigg, H; Kornprat, P; Lackner, C; Haybaeck, J; Pichler, M Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma.
Br J Cancer. 2013; 108(9):1830-1837 Doi: 10.1038/bjc.2013.165 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Koschny, R; Brost, S; Hinz, U; Sykora, J; Batke, EM; Singer, S; Breuhahn, K; Stremmel, W; Walczak, H; Schemmer, P; Schirmacher, P; Ganten, TM Cytosolic and nuclear caspase-8 have opposite impact on survival after liver resection for hepatocellular carcinoma.
BMC Cancer. 2013; 13(5):532-532 Doi: 10.1186/1471-2407-13-532 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Kleine, M; Schrem, H; Vondran, FW; Krech, T; Klempnauer, J; Bektas, H Extended surgery for advanced pancreatic endocrine tumours.
Br J Surg. 2012; 99(1): 88-94. Doi: 10.1002/bjs.7681
Web of Science PubMed FullText FullText_MUG

 

Peck-Radosavljevic, M; Stauber, RE; BCLC - now also an internationally acclaimed prognostic system?.
Liver Int. 2012; 32(7):1037-1038 Doi: 10.1111/j.1478-3231.2012.02840.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sotiropoulos, GC; Tagkalos, E; Fouzas, I; Vernadakis, S; Mathé, Z; Treckmann, J; Paul, A Liver transplantation for hepatocellular carcinoma using extended criteria donor grafts.
Transplant Proc. 2012; 44(9):2730-2733 Doi: 10.1016/j.transproceed.2012.09.021
Web of Science PubMed FullText FullText_MUG

 

2011

Fischer, L; Seiler, CM; Broelsch, CE; de Hemptinne, B; Klempnauer, J; Mischinger, HJ; Gassel, HJ; Rokkjaer, M; Schauer, R; Larsen, PN; Tetens, V; Büchler, MW Hemostatic efficacy of TachoSil in liver resection compared with argon beam coagulator treatment: an open, randomized, prospective, multicenter, parallel-group trial.
Surgery. 2011; 149(1):48-55 Doi: 10.1016/j.surg.2010.02.008
Web of Science PubMed FullText FullText_MUG

 

Hoffmann, K; Hinz, U; Hillebrand, N; Radeleff, BA; Ganten, TM; Schirmacher, P; Schmidt, J; Büchler, MW; Schemmer, P Risk factors of survival after liver transplantation for HCC: a multivariate single-center analysis.
Clin Transplant. 2011; 25(5):E541-E551 Doi: 10.1111/j.1399-0012.2011.01465.x
Web of Science PubMed FullText FullText_MUG

 

Máthé, Z; Tagkalos, E; Paul, A; Molmenti, EP; Kóbori, L; Fouzas, I; Beckebaum, S; Sotiropoulos, GC Liver transplantation for hepatic metastases of neuroendocrine pancreatic tumors: a survival-based analysis.
Transplantation. 2011; 91(5):575-582 Doi: 10.1097/TP.0b013e3182081312
Web of Science PubMed FullText FullText_MUG

 

Zacherl, M; Bernhardt, GA; Zacherl, J; Gruber, G; Kornprat, P; Bacher, H; Mischinger, HJ; Windhager, R; Jakesz, R; Grünberger, T Surgery for liver metastases originating from sarcoma-case series.
Langenbecks Arch Surg. 2011; 396(7):1083-1091 Doi: 10.1007/s00423-011-0821-8
Web of Science PubMed FullText FullText_MUG

 

2009

Reissfelder, C; Rahbari, NN; Koch, M; Ulrich, A; Pfeilschifter, I; Waltert, A; Müller, SA; Schemmer, P; Büchler, MW; Weitz, J Validation of prognostic scoring systems for patients undergoing resection of colorectal cancer liver metastases.
Ann Surg Oncol. 2009; 16(12):3279-3288 Doi: 10.1245/s10434-009-0654-7
Web of Science PubMed FullText FullText_MUG

 

Thalheimer, A; Otto, C; Bueter, M; Illert, B; Gattenlohner, S; Gasser, M; Meyer, D; Fein, M; Germer, CT; Waaga-Gasser, AM The intraportal injection model: a practical animal model for hepatic metastases and tumor cell dissemination in human colon cancer.
BMC Cancer. 2009; 9(2):29-29 Doi: 10.1186/1471-2407-9-29 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2008

Gold, JS; Are, C; Kornprat, P; Jarnagin, WR; Gönen, M; Fong, Y; DeMatteo, RP; Blumgart, LH; D'Angelica, M Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients.
Ann Surg. 2008; 247(1):109-117 Doi: 10.1097/SLA.0b013e3181557e47
Web of Science PubMed FullText FullText_MUG

 

Schrem, H; Till, N; Becker, T; Bektas, H; Manns, MP; Strassburg, CP; Klempnauer, J [Long-term results after liver transplantation].
Chirurg. 2008; 79(2): 121-129. Doi: 10.1007/s00104-007-1457-7
Web of Science PubMed FullText FullText_MUG

 

2007

Tomlinson, JS; Jarnagin, WR; DeMatteo, RP; Fong, Y; Kornprat, P; Gonen, M; Kemeny, N; Brennan, MF; Blumgart, LH; D'Angelica, M Actual 10-year survival after resection of colorectal liver metastases defines cure.
J Clin Oncol. 2007; 25(29):4575-4580 Doi: 10.1200/JCO.2007.11.0833 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2004

Lubienski, A; Bitsch, RG; Schemmer, P; Grenacher, L; Düx, M; Kauffmann, GW Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Rofo. 2004; 176(12):1794-1802 Doi: 10.1055/s-2004-813669
Web of Science PubMed FullText FullText_MUG

 

Stadlbauer, V; Schaffellner, S; Kniepeiss, D; Jakoby, E; Stauber, R; Iberer, F; Tscheliessnigg, KH Experiences in liver transplantation for hepatocellular carcinoma.
Transplant Proc. 2004; 36(1):195-198 Doi: 10.1016/j.transproceed.2003.11.009
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Zacherl, J; Zacherl, M; Scheuba, C; Steininger, R; Wenzl, E; Mühlbacher, F; Jakesz, R; Längle, F Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma.
J Gastrointest Surg. 2002; 6(5):682-689 Doi: 10.1016/S1091-255X(01)00075-0
Web of Science PubMed FullText FullText_MUG

 

2001

Schrem, H; Schütze, S; Klempnauer, J [What's new in hepatobiliary surgery?].
Zentralbl Chir. 2001; 126(8):569-570 Doi: 10.1055/s-2001-16575
Web of Science PubMed FullText FullText_MUG

 

Zacherl, M; Längle, F; Steininger, R; Scheuba, C; Wenzl, E; Jakesz, R; Zacherl, J Surgery for non-colorectal and non-neuroendocrine liver metastases
Wien Klin Wochenschr. 2001; 113(17-18):681-687
Web of Science PubMed

 

1997

Cohnert, TU; Rau, HG; Buttler, E; Hernandez-Richter, T; Sauter, G; Reuter, C; Schildberg, FW Preoperative risk assessment of hepatic resection for malignant disease.
World J Surg. 1997; 21(4):396-400 Doi: 10.1007/PL00012260
Web of Science PubMed FullText FullText_MUG

 

1995

Jatzko, GR; Lisborg, PH; Stettner, HM; Klimpfinger, MH Hepatic resection for metastases from colorectal carcinoma--a survival analysis.
Eur J Cancer. 1995; 31A(1):41-46 Doi: 10.1016%2F0959-8049%2894%2900366-D
Web of Science PubMed FullText FullText_MUG

 

1993

Stauber, RE; Mischinger, HJ; Trauner, M; Pristautz, H Indications for liver transplantation in neoplasms of the liver.
Acta Med Austriaca. 1993; 20(3):57-60
Web of Science PubMed Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum